Analyst - IT at Eli Lilly and Company

Indianapolis, Indiana, United States

Apply Now

Not SpecifiedCompensation

Junior (1 to 2 years), Mid-level (3 to 4 years)Experience Level

Full TimeJob Type

UnknownVisa

Healthcare, Pharmaceuticals, ManufacturingIndustries

Requirements

Excellent leadership and communication skills, cross-functional and within layers of leadership
Strong analytical and problem-solving skills, with the ability to assess risks, manage trade-offs, and make sound decisions
Ability to operate under pressure
Experience managing technology deployments, particularly in the pharma industry
Familiarity with MQ technologies, especially SAP, OneQMS, Tulip, Station Manager, TrackWise, and the appropriate System Validation

Responsibilities

Lead production technology support to ensure smooth and efficient operations
Drive opportunities in full-stack development
Own deviation investigations to identify and resolve issues
Lead proposed modifications and enhancements within applications such as Tulip to optimize technology performance
Oversee major technology project deployments across the site, ensuring projects remain on schedule, risks are proactively mitigated, and stakeholder communication is clear and timely
Present proposals and secure buy-in from site leadership (Flow, Lead Team, Deviation/Change Review Board, etc.)
Lead and manage large-scale programs, ensuring alignment with organizational goals and objectives; drive the technical agenda, liaise between global/local tech teams and the site, and be a member of cross-functional teams that run the plant
Drive to Paperless Mfg: Acceleration and completion of Tulip deployment at the site; develop and implement an appropriate Life Cycle Management agenda with appropriate 24x7x365 support
Create and manage strong relationships: Collaborate with stakeholders across manufacturing to gather requirements, define KPIs, and translate business needs into technical solutions
Ensure the delivery and sustainability of Tech at Lilly solutions and digital manufacturing capabilities to make medicine, with safety first and quality always
Ruthlessly prioritize: Drive the site adoption of assigned solutions, ensuring alignment with Site and Tech at Lilly strategy, and leveraging awareness of internal and external trends in partnership with the Business SMEs

Skills

Full-Stack Development

Deviation Investigations

Tulip

Production Technology

Manufacturing Applications

IAPI

Application Modifications

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free